Estrogens are a family of related molecules that stimulate the development and maintenance of female characteristics and sexual reproduction.
Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells.
The androgen receptor is considered the main driver of the growth and initiation of prostate cancer, which is known to be the second-leading cause of death in men.
In one of the first studies addressing the role of sex hormones' impact on stem cells in the gut, scientists outline new insights showing how a steroidal sex hormone, that is structurally and functionally similar to human steroid hormones, drastically alters the way intestinal stem cells behave, ultimately affecting the overarching structure and function of this critical organ.
In the face of a multipronged front to drive blood pressure up, including a high-salt diet, females are better able to keep their pressure down by increasing levels of a T cell that selectively dials back inflammation, scientists say.
In the watery inside of a cell, complex processes take place in tiny functional compartments called organelles. Energy-producing mitochondria are organelles, as is the frilly golgi apparatus, which helps to transport cellular materials. Both of these compartments are bound by thin membranes.
Essential processes in mammalian cells are controlled by proteins called transcription factors. For example, the transcription factor HIF-1 is triggered by a low-oxygen situation to cause the cell to adapt to decreased oxygen.
Genetic studies covering 266,000 women have revealed 32 new sites on the genome where variations in DNA appear to alter the risks of getting breast cancer.
Researchers at the Center for BrainHealth® recently published findings underscoring differences between men and women's craving or desire to consume cannabis.
A woman's genetic make-up may cause her to gain weight when using a popular form of birth control, according to a study from researchers.
The anti-cancer medicine venetoclax could improve the current therapy for estrogen receptor-positive (ER+) breast cancer - the most common form of breast cancer in Australia - according to preclinical studies led by Walter and Eliza Hall Institute researchers.